Neuralink's "Blindsight" device, developed by Elon Musk's company, aims to restore vision for blind individuals.

New non-invasive ultrasound technique significantly reduces the risk of kidney stone recurrence. Learn more about the ...

Sometimes all it takes is a little push. That is the conclusion of a recently published study in which doctors used a ...

Developing advanced drug screening tools is crucial for the advancement of personalized medicine and the creation of more effective treatments. One organ receiving particular attention in this area is ...

MELBOURNE, Australia, Sept. 17, 2024 (GLOBE NEWSWIRE) -- (ASX: TLX, Telix, the Company) today announces that it has selected ...

A new device could keep organs viable for more than 24 hours - far longer than the current window of four to six hours ...

A noninvasive ultrasound technology called Break Wave lithotripsy (BWL) offers a safe and effective new option for treatment ...

A noninvasive ultrasound technology called Break Wave™ lithotripsy (BWL) offers a safe and effective new option for treatment ...

The app detected high blood pressure with accuracies up to 84% for female participants and 77% for males. "By leveraging ...

Dr David N. Cade, Chief Medical Officer at Telix said, “The results of the ZIRCON trial make a compelling case for TLX250-CDx as a breakthrough product for kidney cancer imaging, and validate CAIX as ...

Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that primary results from its Phase III ZIRCON[1] trial have ...

Laminate Medical Technologies announced that the United States Centers for Medicare & Medicaid Services (CMS) granted the ...